Form 10-K405/A - Annual report [Sections 13 and 15(d), S-K Item 405]: [Amend]
SEC Accession No. 0001095811-01-505035
Filing Date
2001-09-21
Accepted
2001-09-21 00:00:00
Documents
5
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405/A f75847a2e10-k405a.txt 10-K405/A 260634
3 EXHIBIT 10.7.2 f75847a2ex10-7_2.txt EX-10.7.2 17838
4 EXHIBIT 10.16 f75847a2ex10-16.txt EX-10.16 84568
5 EXHIBIT 10.18 f75847a2ex10-18.txt EX-10.18 131440
6 EXHIBIT 23.1 f75847a2ex23-1.txt EX-23.1 972
  Complete submission text file 0001095811-01-505035.txt   496985
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

EIN.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405/A | Act: 34 | File No.: 000-22570 | Film No.: 1741632
SIC: 2833 Medicinal Chemicals & Botanical Products